Brief: Viva Biotech Announces Entered Equity Transfer Agreement
13/09/2023 15:59
Sept 13 (Reuters) - VIVA Biotech Holdings 1873.HK :
* VIVA BIOTECH SHANGHAI, VENDORS AND WEIZONGCHEN
PHARMACEUTICAL
SERVICES (SHANGHAI) CO ENTERED EQUITY TRANSFER AGREEMENT
* UNDER AGREEMENT, WEIZONGCHEN PHARMACEUTICAL REQUIRED TO
BUY
EQUITY INTEREST IN LANGHUA PHARMACEUTICAL FROM VENDORS
* UNDER AGREEMENT, WEIZONGCHEN PHARMACEUTICAL REQUIRED TO
ACQUIRE
EQUITY INTEREST IN LANGHUA PHARMACEUTICAL FOR TOTAL RMB640
MILLION
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical